Page last updated: 2024-10-31

mitoxantrone and Skin Ulcer

mitoxantrone has been researched along with Skin Ulcer in 2 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Skin Ulcer: An ULCER of the skin and underlying tissues.

Research Excerpts

ExcerptRelevanceReference
"A 23-year-old man with acute myelogenous leukemia (AML) (M2) who was pretreated with chemotherapy for autologous bone marrow transplantation developed a skin ulcer on the left groin."1.39Dermatic Scedosporium apiospermum infection after autologous bone marrow transplantation. ( Chen, H; Hu, J; Hu, L; Jiang, M; Li, B; Li, Y; Lou, X; Ning, H; Wang, J; Xu, C; Yu, Z, 2013)
"Mitoxantrone is a new active anthracene-based, DNA intercalator which is undergoing widespread clinical testing for antitumor efficacy in man."1.27Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantrone. ( Alberts, DS; Dorr, RT; Soble, M, 1986)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yu, Z1
Hu, L1
Jiang, M1
Ning, H1
Xu, C1
Li, B1
Li, Y1
Lou, X1
Wang, J1
Hu, J1
Chen, H1
Dorr, RT1
Alberts, DS1
Soble, M1

Other Studies

2 other studies available for mitoxantrone and Skin Ulcer

ArticleYear
Dermatic Scedosporium apiospermum infection after autologous bone marrow transplantation.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:6

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Comb

2013
Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantrone.
    Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:2

    Topics: Animals; Anthraquinones; Cisplatin; Drug Evaluation, Preclinical; Female; Injections, Intradermal; I

1986